| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/31/2007 | CA2630465A1 Antineoplastic compounds |
| 05/31/2007 | CA2630271A1 Fused bicyclic mtor inhibitors |
| 05/31/2007 | CA2629554A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/31/2007 | CA2629544A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents |
| 05/31/2007 | CA2628958A1 Thiazoles for the treatment of proliferative disorders |
| 05/31/2007 | CA2628920A1 Pyrido-,pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
| 05/31/2007 | CA2628330A1 F,g,h,i and k crystal forms of imatinib mesylate |
| 05/31/2007 | CA2628126A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/31/2007 | CA2593718A1 Napthyridine compounds as rock inhibitors |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790717A2 Compositions and methods for the identification of lung tumor cells |
| 05/30/2007 | EP1790664A1 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 05/30/2007 | EP1790663A1 Monoclonal antibody(ad5-10) against tumor necrosis factor-related apoptosis-inducing ligand receptor dr5, the producing method and uses thereof |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790653A2 Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it |
| 05/30/2007 | EP1790652A1 Polycyclic guanine phosphodiesterase V inhibitors |
| 05/30/2007 | EP1790650A1 Novel substituted imidazole derivatives |
| 05/30/2007 | EP1790644A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790342A1 Pyridopyrazine derivatives and their use as signal transduction modulators |
| 05/30/2007 | EP1790340A2 Combination chemotherapy |
| 05/30/2007 | EP1790335A1 Composition and its use for the manufacture of a medicament for treating, prophylactically treating, preventing cancer and/or infections in the urinary tract |
| 05/30/2007 | EP1789552A2 Methods of regulating differentiation and treating of multiple myeloma |
| 05/30/2007 | EP1789549A1 Method for treating synovial sarcoma using sirna for fzd10 |
| 05/30/2007 | EP1789451A2 Tie complex binding proteins |
| 05/30/2007 | EP1789420A2 6H-[1]BENZOPYRANO[4,3-b]QUINOLINES AND THEIR USE AS ESTROGENIC AGENTS |
| 05/30/2007 | EP1789417A1 AMIDE DERIVATIVES OF 7-AMINO-3-PHENYL-DIHYDROPYRIMIDO [4,5-d]PYRIMIDINONES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS |
| 05/30/2007 | EP1789416A2 Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 05/30/2007 | EP1789406A1 Thioxothiazolidinone compounds for use as pharmaceuticals |
| 05/30/2007 | EP1789400A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/30/2007 | EP1789399A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/30/2007 | EP1789390A2 Pyridyl inhibitors of hedgehog signalling |
| 05/30/2007 | EP1789361A1 Water-soluble nanoparticles stabilized with multi-functional group ligands and method of preapation thereof |
| 05/30/2007 | EP1789107A2 Medical stent provided with inhibitors of atp synthesis |
| 05/30/2007 | EP1789064A1 Improved anticancer treatment |
| 05/30/2007 | EP1789056A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 05/30/2007 | EP1789055A2 Thiazolopyridine kinase inhibitors |
| 05/30/2007 | EP1789046A2 Peripheral benzodiazepine receptor independent superoxide generation |
| 05/30/2007 | EP1789042A2 1-alkoxy 1h-imidazo ring systems and methods |
| 05/30/2007 | EP1789033A2 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 05/30/2007 | EP1789030A2 Medical implant provided with inhibitors of atp synthesis |
| 05/30/2007 | EP1789029A2 Methods and compositions for the treatment of cell proliferation |
| 05/30/2007 | EP1789027A2 Therapeutic use of anti-tf-antigen antibody |
| 05/30/2007 | EP1538888A4 Upper hitch link |
| 05/30/2007 | EP1499577B1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 05/30/2007 | EP1496925A4 Use of interleukin-24 to treat ovarian cancer |
| 05/30/2007 | EP1492560A4 Use of interleukin-19 to treat cervical cancer |
| 05/30/2007 | EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation |
| 05/30/2007 | EP1417211B1 Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1292335B1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 05/30/2007 | EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 05/30/2007 | EP1263723B1 Ningalin b analogs employable for reversing multidrug resistance |
| 05/30/2007 | EP1257537B1 Therapeutic morpholino-substituted compounds |
| 05/30/2007 | EP1221973B1 CD40 antagonist for treating psoriasis |
| 05/30/2007 | EP1206274B1 Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP0819121B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | CN1972955A Radiosensitizer |
| 05/30/2007 | CN1972935A Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient |
| 05/30/2007 | CN1972934A 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 05/30/2007 | CN1972930A Novel pyridazinone derivatives as inhibitors of CDK2 |
| 05/30/2007 | CN1972925A Substituted bisarylurea derivatives |
| 05/30/2007 | CN1972908A N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
| 05/30/2007 | CN1972703A Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and detecting protease inhibitors |
| 05/30/2007 | CN1972698A Beta-hydroxy short to medium chain fatty acid polymer |
| 05/30/2007 | CN1972688A 4-phenylamino-quinazolin-6-yl-amides |
| 05/30/2007 | CN1970579A High substitution degree carboxymethyl indianbread polysaccharide and its preparation method and uses |
| 05/30/2007 | CN1970576A Extraction and preparation process of polysaccharide of Pteris semipinnata L. with anticancer activity |
| 05/30/2007 | CN1970572A Interferon alpha mutant and its polyethylene glycol derivative |
| 05/30/2007 | CN1970552A Substituted[1,3,5] triazine compound, its preparing process and its application |
| 05/30/2007 | CN1970543A Synthesis and uses of serial ion liquid as candidate drug with anticancer activity |
| 05/30/2007 | CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 05/30/2007 | CN1970087A Organic metal carborane target formulation and its preparation method |
| 05/30/2007 | CN1970085A Orally disintegrating tablet of ubenimex and preparation method thereof |
| 05/30/2007 | CN1970078A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970077A Peptides and related molecules that bind to tall-1 |
| 05/30/2007 | CN1970075A Lyophilized powder injection of glutathione and preparation process thereof |
| 05/30/2007 | CN1970074A Application of beta-protein inhibitor in preparation of medicament for treating genetic correlated disease |
| 05/30/2007 | CN1970054A Method for extracting anticancer extract from citronella oil, composition and use thereof |
| 05/30/2007 | CN1970042A Chinese herbal capsule for reducing cancerous protuberance and dispelling toxins |
| 05/30/2007 | CN1970036A Chinese medicinal decoction for treating leucopenia caused by cancer radiochemical therapy and method for preparing same |
| 05/30/2007 | CN1970028A Detoxifying formulation containing astragalus root and greenbrier and preparation process thereof |
| 05/30/2007 | CN1969931A Chinese medicinal dispersible tablet for treating acute, chronic and persistent hepatitis and liver cancer |
| 05/30/2007 | CN1969930A Method for preparing rhodiola root extract transformed by microbe |
| 05/30/2007 | CN1969888A Method for preparing soft capsule of ground bettle |
| 05/30/2007 | CN1969887A Method for extracting propolis functional ingredient by using microwave technology |
| 05/30/2007 | CN1969876A Lyophilized injection of lentinan and preparation process thereof |
| 05/30/2007 | CN1969854A Sustained release formulation of raltitrexed and preparation method thereof |
| 05/30/2007 | CN1969853A Use of N-aryl heterocyclics |
| 05/30/2007 | CN1969836A Ferulic acid and sodium ferulate preparation for inducing stem cell differentiating into nerve stem cell and pharmaceutical application thereof |
| 05/30/2007 | CN1969833A Dry powder composition containing CoQ10 and preparation process thereof |
| 05/30/2007 | CN1969828A Anticancer sustained release injection containing mesenchyme hydrolytic agent |
| 05/30/2007 | CN1969827A Anti-solid tumor composition containing epothilone and mesenchyme hydrolytic agent |
| 05/30/2007 | CN1969826A Fluorouracil and its synergist carried sustained release agent |
| 05/30/2007 | CN1969825A Sustained release agent containing fluorouracil and synergist thereof |